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Plinical Outcome of 193 Extracardiac Fontan Patients
he First 15 Years
alvatore Giannico, MD,* Fatma Hammad, MD,† Antonio Amodeo, MD,* Guido Michielon, MD,*
abrizio Drago, MD,* Attilio Turchetta, MD,† Roberto Di Donato, MD,*
tephen P. Sanders, MD, FACC*
ome, Italy
OBJECTIVES We sought to evaluate the mid-term outcome of hospital survivors with extracardiac Fontan
circulation.
BACKGROUND Few data exist about the mid-term and long-term results of the extracardiac Fontan
operation.
METHODS From November 1988 to November 2003, 221 patients underwent an extracardiac Fontan
procedure as primary (9 patients) or secondary (212 patients) palliation, at a mean age of 72.2
months (range 13.1 to 131.3 months). A total of 165 of 193 early survivors underwent
programmed noninvasive follow-up evaluations and at least one cardiac catheterization.
RESULTS The overall survival, including operative deaths, was 85% at 15 years. Freedom from late
failure among hospital survivors is 92% at 15 years. A total of 127 of 165 survivors (77%) were
in New York Heart Association functional class I. The incidence of late major problems was
24% (42 major problems in 36 of 165 patients): 19 patients had arrhythmias (11%), 5 patients
had obstruction of the extracardiac conduit (3%) and 6 of the left pulmonary artery (3.5%),
and 5 patients experienced ventricular failure (3%), leading to heart transplantation in 3
patients. Protein-losing enteropathy was found in two patients (1%). The incidence of late
re-interventions was 12.7% (21 of 165 patients, including 15 epicardial pacemaker implan-
tations). Four patients died (2.3%), two after heart transplantation.
CONCLUSIONS After 15 years of follow-up, the overall survival, the functional status, and the cardiopulmo-
nary performance of survivors of the extracardiac Fontan procedure compare favorably with
other series of patients who underwent the lateral tunnel approach. The incidence of late
deaths, obstructions of the cavopulmonary pathway, re-interventions, and arrhythmias is
lower than that reported late after other Fontan-type operations. (J Am Coll Cardiol 2006;
ublished by Elsevier Inc. doi:10.1016/j.jacc.2005.12.06547:2065–73) © 2006 by the American College of Cardiology Foundation
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tefore the Fontan operation, complex cardiac anomalies
hat were unsuitable for biventricular repair were palliated
y pulmonary artery banding or systemic-to-pulmonary
hunts. Nevertheless, the life expectancy was only two to
hree decades.
The introduction of the Fontan operation dramatically
hanged the management of patients with a functional
ingle ventricle. Thirty-four years after the first description
f total right heart bypass (1), one or another modification
f the Fontan operation has become one of the most
requently performed operations for congenital heart dis-
ase. The separation of systemic and pulmonary venous
eturns results in near-normal systemic oxygen saturation
nd normalizes the volume work of the systemic ventricle.
ow children, adolescents, and adults with a functional
ingle ventricle can experience a normal lifestyle.
This extensive application of the Fontan principle is
urrently under intensive scrutiny. After the earlier pessi-
istic reports about long-term outcome (2–4) and the more
ecent experience reported by Gentles et al. (5), it remains
From the *Departments of Pediatric Cardiology and Cardiac Surgery and †Pedi-
trics, Bambino Gesu˘ Hospital, Rome, Italy. This paper is dedicated to the memory
f the late Dr. Cosimo Squitieri.r
Manuscript received August 3, 2005; revised manuscript received December 5,
005, accepted December 30, 2005.nclear whether the Fontan principle provides satisfactory
alliation for patients with a single ventricle, and if so,
hich operative strategy affords the best late outcome.
Since 1988, right heart bypass has been accomplished by
eans of a total cavopulmonary connection (6), achieved
sing a lateral tunnel, an intra-atrial conduit, or an extra-
ardiac conduit. We have reported the technical advantages
7), the hemodynamic benefits, and the patterns of cavo-
ulmonary flow of the extracardiac Fontan procedure (8), as
ell as its application in complex cardiac anomalies (9,10).
hysical models as well as mathematical models have
onfirmed the hemodynamic benefits of the extracardiac
ontan procedure (11).
The feasibility of a fenestration in the extracardiac Fontan
onnection as well as the potential for conversion of a
revious atriopulmonary connection have been reported
12–15).
The potential advantages of the extracardiac Fontan
rocedure include avoidance of myocardial ischemia (aortic
ross-clamping), atriotomy, and intra-atrial suture lines, as
ell as the feasibility of early or late fenestration. However,
he capacity of this procedure to reduce late atrial arrhyth-
ias and the longevity of the extracardiac conduit remain
nproven (16–19). We reviewed our total experience with
he extracardiac Fontan procedure and report mid-term
esults in the first 193 survivors.
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tudy group. All patients who underwent a primary or
econdary extracardiac Fontan procedure at Bambino Gesu˘
ediatric Hospital between November 1988 and November
003 were identified by searching the computer database of
he Follow-Up Unit of Congenital Cardiac Patients. The
edical records of each patient were reviewed, and the
ollowing information was collected: clinical status, medi-
ation, cardiovascular test results including electrocardio-
ram, Holter monitoring, exercise test, echocardiogram,
ardiac magnetic resonance imaging (MRI), and cardiac
atheterization. The scheduled tests performed in the
ollow-Up Unit are reported in Table 1. In addition,
omplications, interventional catheterization procedures,
nd surgical procedures were recorded.
An age- and gender-matched control population was
dentified for comparison of cardiovascular test results
20,21). The control group of normal children are one from
ur laboratory (20) and one from another institution (21).
A maximal exercise stress test was performed in patients
ver five years of age following the Bruce protocol once per
ear. Lung function testing was performed in all patients by
pneumotachograph, measuring the best of three consecu-
ive flow-volume curves. Forced vital capacity (FVC), forced
xpiratory volume in 1 s (FEV1), and forced expiratory
ow were considered as absolute values and as percent-
ges of predicted values. Magnetic resonance imaging
as performed in all patients as previously reported (10).
ostoperative cardiac catheterization and angiography
ere performed at least once in all survivors following our
rotocol (8).
tatistical analysis. Numeric data are presented as mean
alue  1 SD. The primary outcome variable in this study
as survival with an intact Fontan circulation. Failure was
efined as death or takedown of the Fontan circulation to an
ortopulmonary or cavopulmonary shunt, or heart trans-
lantation. Early failure was defined as death or takedown
ithin 30 days from surgery or death before hospital
ischarge. Secondary end points were functional class,
revalence of arrhythmias, and late complications of the
able 1. Standard Noninvasive Evaluation in 165 Survivors
hysical examination Every 6 months
lectrocardiogram Every 6 months
chocardiogram Every 6 months
4-h ambulatory electrocardiographic recordings Once per yr
readmill exercise test Once per yr
ung function test/blood sampling Once per yr
Abbreviations and Acronyms
FEV1  forced expiratory volume in 1 s
FVC  forced vital capacity
MRI  magnetic resonance imagingaagnetic resonance imaging Every 2 yrsontan circuit resulting in interventional procedures. Sur-
ival data and probability of freedom from time-related
vents were analyzed by the product limit method of Kaplan
nd Meier.
Normograms of the hazard functions for the following
nd points were obtained: death or heart transplantation,
bstruction of the cavopulmonary pathway, arrhythmia,
e-intervention, and pacemaker implantation.
Comparisons of rest and exercise values between the
ontrol and the extracardiac Fontan groups were made using
two-tailed t test for unpaired data. Statistical analysis was
onducted with SAS 1998 statistical software (SAS Institute
nc., Cary, North Carolina).
ESULTS
tudy group. From November 1988 to November 2003,
21 patients, mean age 6 years (range 1 to 10.9 years),
nderwent an extracardiac Fontan operation at our institu-
ion. An extracardiac conduit or a direct anastomosis was
sed to connect the inferior vena cava to the pulmonary
rtery in all cases (7). The superior vena cava was anasto-
osed to the ipsilateral pulmonary artery either at the time
f the Fontan operation (nine patients) or as a bidirectional
avopulmonary anastomosis performed previously. The 60
atients with complex cardiac anomalies who underwent
urgery between 1988 and 1995 represent a subgroup
reviously reported (10).
During this period, 16 additional patients underwent a
ontan operation using another technique (lateral tunnel in
ine and atriopulmonary connection in seven patients).
election was based on the surgeon’s preference. This
umber of patients is insufficient for comparison with the
xtracardiac Fontan group. This group will not be described
urther.
Of the initial 221 patients, 193 survived to hospital
ischarge with the Fontan circulation intact, 22 died early
ostoperatively, and 6 patients survived an emergency take-
own of the Fontan procedure. The early failure rate
ecreased from 14.8% (17 of 115 patients) in the first 10
ears to 4.7% (5 of 106 patients) in the last 5 years. The
ean follow-up was 63 months, and the median follow-up
as 50 months (range 1 to 179 months). For 36 patients the
ollow-up was longer than 10 years. The total follow-up was
,122 patient/years. A total of 28 of 193 patients were lost
o follow-up because they returned to their country of origin
uring follow-up. Preoperative diagnoses in 193 early sur-
ivors (165 in follow-up and 28 lost to follow-up) are
ummarized in Table 2. We analyzed the clinical data of
atients lost to follow-up, including age, disease, time of the
xtracardiac Fontan procedure, type of conduit used, early
ostoperative data, and early follow-up data. The patients
ost to follow-up did not differ significantly from the other
urvivors.
urgical aspects. A total of 9 of 193 survivors underwent
n extracardiac Fontan procedure as the primary surgical
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May 16, 2006:2065–73 Outcome of the Extracardiac Fontanrocedure. Previous surgical procedures of the survivors in
ollow-up are reported in Table 3 and reflect our policy of a
taging toward a Fontan procedure (22–24).
In 10 patients, a previous atriopulmonary connection was
onverted to an extracardiac Fontan because of obstruction
f the Fontan pathway or persistent atrial arrhythmias
15,25). The additional surgical procedures performed at
he time of the extracardiac Fontan are reported in Table 3.
Dacron conduits were used until 1997 (N  43). Also,
efore 1997 an aortic homograft was used in three patients.
ince 1997 we have used only polytetrafluoroethylene Gore-
ex conduits (N  113) to minimize the risk of peel
ormation (10). The range of conduit sizes was 16 to 24
m. In four patients, the inferior vena cava was anasto-
osed directly to the right pulmonary artery (26). In three
ther patients, the superior vena cava was connected to the
eft pulmonary artery and the inferior vena cava was con-
ected to the right pulmonary artery (27).
The extracardiac conduit was fenestrated in 52 of 193
arly survivors using a small Gore-Tex conduit interposed
etween the extracardiac conduit and the atrial wall or a
-mm direct connection between the side of the conduit and
he atrial wall. The main indication for a fenestrated
xtracardiac Fontan was the small size of the pulmonary
rteries. Myocardial ischemia (aortic cross-clamping) was
voided in 128 of 193 patients.
linical outcome. Of the 165 early survivors in follow-up,
27 (77%) are in New York Heart Association functional
lass I, 31 patients (19%) are in class II, and 5 patients (3%)
re in class III. All 165 patients in follow-up received oral
nticoagulation agents for at least six months after surgery
nd subsequently antiaggregate therapy with aspirin. No
atient had a bleeding complication of the anticoagulant
herapy. A total of 98 of 165 patients enrolled were taking
edications, including digoxin, furosemide angiotensin-
onverting enzyme inhibitors, and antiarrhythmic drugs.
hirty-six patients (22% of the 165 survivors) experienced
2 major late complications (Fig. 1). The overall freedom
rom failure of the Fontan procedure (early and late) by
aplan-Meier curve is 89% at 5 years and 85% at 10 and 15
ears. Freedom from late failure among those who survived
o hospital discharge with the Fontan circulation intact is
able 2. Preoperative Diagnosis in 165 Survivors on Follow-Up
nd in 28 Patients Lost to Follow-Up
Survivors
Lost to
Follow-Up
ricuspid atresia 37 8
ouble-inlet left ventricle 35 5
omplex congenital heart diseases
(functional single ventricle)
44 7
eterotaxy syndrome 27 4
ypoplastic left heart syndrome 11 2
ulmonary atresia and intact
ventricular septum
11 2
otal 165 284.2% at 10 years and 92.2% at 15 years (Fig. 2).xercise tolerance and lung function test. Maximal ex-
rcise stress testing showed a moderate reduction of exercise
olerance (62.4% of predicted value, range 58% to 65%).
he heart rate at the peak of exercise was significantly lower
han in the control group (161  19 beats/min; control
ubjects, 182 6 beats/min; p 0.001) as was the maximal
ystolic arterial pressure (116  10 mm Hg; control sub-
ects, 130  9 mm Hg, p  0.005). Systemic oxygen
aturation decreased during exercise from 92% to 88%
mean value) in the patients without fenestration and from
9% to 80% (mean value) in the six patients with the
enestration left open. The level of exercise tolerance re-
ained stable during follow-up in 127 of 165 (77%) patients
ithout major late complications (Table 4). Exercise tests
ere not performed regularly in the 38 patients with late
omplications or late deaths, or if performed, the results
ere too variable to permit detection of a trend. Measures of
he cardiac output and the oxygen consumption during the
tress test were obtained in 64 of 165 patients. Cardiac
utput increased from 3.04  0.75 l/min to 4.5  2.02
/min at maximal exercise.
A restrictive ventilatory pattern, defined as FVC and
EV1 80% of predictive, with FEV1/FVC  80% of
redicted, was identified in 45 patients during follow-up
mild in 27 patients and moderate in 18 patients). In most
f these patients, previous cardiothoracic surgical proce-
ures are the most likely cause. Four patients had an
bstructive ventilatory pattern, defined as FVC  80% of
redicted but FEV1 and FEV1/FVC 80% of predicted.
onduit function assessment. In 154 of 165 survivors,
chocardiography showed laminar, predominantly diastolic,
avopulmonary flow with typical respiratory variation. In
hese patients, MRI imaging showed uniform reduction of
he internal conduit diameter of 17.2  6.4% during the
rst 6 months with no progression over the following years
17.5  5.8%, p  not significant). In all survivors in
ollow-up, we analyzed at least two MRI images (the first
able 3. Previous Surgical Procedures in 193 Survivors
ystemic-to-pulmonary artery shunt 69
ulmonary banding 21
orwood stage I 13
idirectional cavopulmonary anastomosis 114
idirectional cavopulmonary anastomosis  Damus Kaye Stansel 35
idirectional cavopulmonary anastomosis  tricuspid excision 4
triopulmonary Fontan 10
picardial pacemaker implantation 7
tent implantation in pulmonary arteries 6
epair total anomalous pulmonary venous connection 5
ulmonary valvulotomy 3
lalock-Hanlon (isolated procedure) 3
ortic arch repair 3
alloon valvuloplasty of pulmonary valve stenosis 1
ake-down palliative Mustard 1
dditional surgical procedures in 165 survivors
Epicardial pacemaker implantation 9
Replacement of aortic root and aortic valve plasty 4
Tricuspid valve annuloplasty 3
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Outcome of the Extracardiac Fontan May 16, 2006:2065–73ithin six months of the Fontan procedure and the second
t least two years later). In 108 of 165 patients, an additional
RI was analyzed an average of 2 years after the second
xamination.
igure 1. Outcome of 193 survivors. Thirty-six patients experienced 42 la
One patient with sinus dysfunction and left pulmonary artery (LPA) sten
entricular failure and conduit stenosis. *One patient with ventricular failure
One patient with atrioventricular block (AVB) and LPA stenosis. AVR 
alloon angioplasty; PMK  pacemaker.
igure 2. Kaplan-Meier estimates of the probability of freedom from late
ontan failure (probability of survival with an intact Fontan circulation;
ime zero is discharge from the hospital or the 30th day after surgery).
atients who did not experience a late failure of the Fontan circulationdeath, takedown, or heart transplantation) were censored at the time of the
ast follow-up.
SAngiography of the cavopulmonary pathway indicated no
hrombus formation among survivors and no graft stenosis
n 154 of 165 survivors. The remaining 11 patients had
bstruction of the cavopulmonary pathway. In five patients
3%), there was a significant obstruction of the extracardiac
onduit (Table 5). Echocardiographic Doppler patterns of
he flow inside the conduit were different in the five patients
ith conduit stenosis: forward flow was laminar during a
ormal inspiratory phase, but showed turbulent features
ith increased Doppler velocities during a forced, deep
nspiration. Three of these five patients underwent success-
ul stent implantation, and one patient underwent successful
mplications: 6 patients with 2 complications are indicated with asterisks.
‡One patient with conduit stenosis and LPA stenosis. §One patient with
atrial arrhythmias. #One patient with ventricular failure and LPA stenosis.
tic valve replacement; HT  heart transplantation; PBA  percutaneous
able 4. Exercise Data During Follow-Up in 127 of 165
atients Without Major Late Complications
Follow-Up
1 yr 5 yrs 10 yrs
xercise tolerance
(% of predicted value)
62.4  4 60  3 59  5
eart rate at peak (beats/min) 161  19 155  17 152  15
aximal systolic arterial pressure
(mm Hg)
116  10 120  8 125  6te co
osis.
andystemic oxygen saturation (%) 88  3 86  4 87  3
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May 16, 2006:2065–73 Outcome of the Extracardiac Fontanalloon angioplasty. The remaining patient with calcifica-
ion of a 16-mm homograft conduit underwent surgical
eplacement, performed without aortic cross-clamping and
ompleted with normothermic circulation and a beating
eart (Table 5). One patient had both conduit stenosis
resolved by balloon angioplasty) and left pulmonary artery
tenosis treated successfully by stent implantation. Six sur-
ivors presented late with stenosis of the left pulmonary
rtery. Four patients underwent successful stent implanta-
ion, and two underwent percutaneous balloon angioplasty
ith clinical improvement. Cumulative freedom from cavo-
ulmonary pathway obstruction was 96% at 5 years, 93.3%
t 10 years, and 89% at 15 years (Fig. 3). There was no
ignificant relationship between the size of the conduit and
ate outcome.
alve function. Twenty-one patients had mild-to-
oderate regurgitation and three had moderate regurgita-
ion of a common atrioventricular valve. Three patients with
ypoplastic left heart syndrome had severe tricuspid regur-
itation leading to valve annuloplasty at the time of the
xtracardiac Fontan procedure. Six patients had mild-to-
oderate aortic insufficiency. Four of these had undergone
urgical repair of the aortic valve at the time of the
xtracardiac Fontan procedure, and one subsequently un-
erwent aortic valve replacement.
entricular function. Five patients (3%) showed signs of
entricular failure (high caval and pulmonary mean pres-
ures, high end-diastolic ventricular pressure). Two of them
able 5. Patients With Conduit Obstruction
Age at Fontan
Procedure
(months) Conduit Reintervention
152 Dacron no. 22 Stenting
71 Dacron no. 18 Stenting
90 Dacron no. 20 Percutaneous balloon angiopl
39 Homograft no. 16 Replacement
35 Dacron no. 18 Stenting
igure 3. Kaplan-Meier estimates of the probability of freedom from
avopulmonary pathway obstructions and catheter-based re-intervention.l
ime zero in this and subsequent graphs is 30 days after extracardiac
ontan procedure.re receiving anticongestive therapy. The other three under-
ent heart transplantation with two hospital deaths.
enestration. In all survivors with a fenestration, the small
onduit interposed between the main conduit and the atrial
all or the 4-mm circular hole was easily visualized by
chocardiography in the subcostal or apical four-chamber
iew. The flow across the fenestration was continuous and
aminar in the first 15 to 20 days after surgery and became
urbulent and subsequently absent in the small conduit at
he end of the first month because of the spontaneous
losure of the fenestration.
A total of 29 of 52 fenestrations had spontaneously closed
t the echocardiographic or catheterization study, at a mean
f 2 months after the fenestrated Fontan procedure. Trans-
atheter complete occlusion was performed in 17 of 23
atients with open fenestration 6 to 18 months later. In the
emaining six patients, the fenestration was left open because of
he hemodynamic data. The spontaneous or transcatheter
cclusion of the fenestration produced a significant increase of
he systemic oxygen saturation (from 85% to 93%), but there
as no evident relationship with late outcome.
ate arrhythmias. The predominant rhythm was sinus in
27 of 165 survivors and junctional in 38 patients with
oderate nocturnal bradycardia caused by sinus node
ysfunction.
Nineteen patients (11% of the 165 survivors) had late
rrhythmias. Three of 19 underwent epicardial pacemaker
mplantation because of progressive complete atrioventric-
lar block associated with an L ventricular loop. Nine of 19
atients had an epicardial pacemaker implanted to treat sinus
ode dysfunction, according to current guidelines (28).
Seven of 19 patients had atrial arrhythmias (recurrent
trial flutter or fibrillation, or paroxysmal supraventricular
achycardia), late after the Fontan procedure. All patients
ad symptoms of heart failure and/or low cardiac output
uring the episodes of atrial arrhythmia. All seven patients
ere treated medically, and three underwent pacemaker
mplantation because of drug-induced bradycardia. One of
hese latter three patients subsequently underwent successful
eart transplantation. Kaplan-Meier cumulative freedom
rom arrhythmias was 91% at 5 years, 87.4% at 10 years, and
3.8 at 15 years (Fig. 4).
ncommon cardiac-related events. At 18 and 22 months
fter the extracardiac Fontan operation, protein losing-
nteropathy developed in two patients, one with hypoplastic
Time of
Reintervention
(months) Follow-Up
65 Heart transplantation and death 2 months later
76 Satisfactory outcome at 83 months
50 Satisfactory outcome at 87 months
48 Satisfactory outcome at 83 months
144 Satisfactory outcome at 15 monthsastyeft heart syndrome and the other with asplenia syndrome.
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Outcome of the Extracardiac Fontan May 16, 2006:2065–73erebral thromboembolism occurred in one patient in
ssociation with bacterial endocarditis of the common
trioventricular valve.
In one patient with tricuspid atresia and transposition of
he great arteries, severe subaortic stenosis developed 10
onths after the extracardiac Fontan (performed as primary
alliation), and the patient underwent successful surgical
elief of the obstruction. One patient underwent a successful
ortic valve replacement for severe aortic regurgitation 118
onths after the Fontan operation.
e-interventions. Catheter-based re-interventions (dila-
ion or stent implantation) were performed in 10 patients
or conduit stenosis, left pulmonary artery stenosis, or both
Table 6). Six patients underwent surgical re-interventions
or hemodynamic or anatomic problems, including one
onduit replacement, three heart transplantations, one sub-
ortic stenosis resection, and one aortic valve replacement.
n epicardial pacemaker was implanted for bradyarrhyth-
ia, heart block, or to permit drug treatment of atrial
achyarrhythmias in 15 patients (re-interventions for
hythm disturbances). Kaplan-Meier cumulative freedom
rom all re-interventions is 81% at 10 years and 69.4% at 15
ears (Fig. 5). Kaplan-Meier cumulative freedom from
acemaker implantation (the most frequent reoperation)
as 88.7% at 10 years and 76.2% at 15 years (Fig. 6).
aplan-Meier cumulative freedom from catheter-based re-
nterventions is shown in Figure 3.
able 6. Reinterventions
atheter-based reinterventions 10
Stenting of the LPA 4
Stenting of the conduit 3
PBA of the LPA 2
PBA of the conduit 1
urgical reinterventions for hemodynamic/anatomic problems 6
Heart transplantation 3
Extracardiac conduit replacement 1
Subaortic resection 1
Aortic valve replacement 1
urgical reinterventions for rhythm disturbances 15
Epicardial pacemaker implantation 15
igure 4. The Kaplan-Meier estimates of the probability of freedom from
rrhythmia.F
pPA  left pulmonary artery; PBA  percutaneous balloon angioplasty.ate deaths. There were four late deaths. Two patients
ith a pacemaker died suddenly at home. Two deaths
ccurred after heart transplantation.
ISCUSSION
ostoperative physiology of extracardiac Fontan. SUR-
IVAL. Our series of survivors with an extracardiac Fontan
irculation is the largest series reported in the literature and
as the longest follow-up. The overall survival (including
ospital deaths) in our patients is 85% at 10 and 15 years,
omparable with those reported for intra-atrial cavopulmo-
ary connections (2–5) (Table 7). However, actuarial sur-
ival for those discharged from the hospital with the extra-
ardiac Fontan intact is 92.2% at 15 years. Further, 77% of 165
urvivors in regular follow-up have no symptoms during
ormal daily life, with a satisfactory exercise tolerance and a
ild exercise-induced decrease in systemic saturation, com-
on after a Fontan procedure (29).
AVOPULMONARY CIRCULATION. Cardiopulmonary func-
ion after Fontan procedures depends on several factors, all
nfluencing the dynamics of cavopulmonary flow. Our
chocardiographic Doppler studies confirm that forward
avopulmonary flow is predominantly an early diastolic
vent, in contrast to what occurs in atriopulmonary connec-
igure 5. The Kaplan-Meier estimates of the probability of freedom from
ll re-interventions.igure 6. The Kaplan-Meier estimates of the probability of freedom from
acemaker implantation.
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May 16, 2006:2065–73 Outcome of the Extracardiac Fontanions. This hemodynamic model with blood flowing from
enae cavae to the pulmonary artery through a tubular
ystem, interposed between the systemic and pulmonary
apillary beds, reduces energy loss, especially compared with
he atriopulmonary connection. This model emphasizes the
otential role of diastolic ventricular performance (as a
uction pump) in Fontan circulation (8–30). Further inva-
ive studies with a simultaneous measurement of the for-
ard cavopulmonary flow and the ventricular diastolic
ressure variations should help to define the role of the
iastolic ventricular performance.
Experimental or computerized fluid dynamics studies
uggest that all types of cavopulmonary connection are
fficient for reducing energy losses (31,32), but the
xtracardiac conduit seems to provide the least fluid
nergy dissipation at all flow rates and especially at high
ows (33). Moreover, the spatial arrangement of the
xtracardiac conduit that minimizes energy loss is with
he conduit oriented to the left pulmonary artery and the
uperior vena cava to the right pulmonary artery. This
patial arrangement produces a beneficial vortex that
acilitates cavopulmonary forward flow, especially at high
ow rates (11).
Our results in the subgroup of 10 patients who underwent
evision of a previous atriopulmonary connection to an
xtracardiac Fontan circulation are promising. If these
bservations are corroborated by further experience, more
ailed atriopulmonary Fontan patients could be converted to
n extracardiac Fontan procedure as an alternative to heart
ransplantation.
ARDIOPULMONARY FUNCTION. The typical respiratory
ariations of the cavopulmonary flow, analyzed by echocar-
iographic Doppler in our patients early after the surgery
8), were also seen later in follow-up and show that
ulmonary flow is clearly dependent on respiratory motion
inspiratory suction). This respiratory mechanism becomes
rucial during exercise to increase cavopulmonary flow, prob-
bly because the increased resting venous tone in patients with
ontan procedures may limit their ability to mobilize blood
rom capacitance vessels during exercise (34).
ate complications of extracardiac Fontan. EXTRACARDIAC
ONDUIT OBSTRUCTION. The longevity of the extracardiac
onduit remains the most controversial aspect of this surgi-
al option. In our series of the 165 survivors, including the
6 patients with the longest follow-up (more than 10 years),
able 7. 10-Year Survival After Fontan-Type Operation
Number of
Patients
Years of
Operation
Survival
(%)
ontan et al. (2) 1990 334 1975–1988 69%
riscoll et al. (3) 1992 352 1973–1984 70%
etta et al. (4) 1992 339 1987–1992 81%
entles et al. (5) 1997 500 1973–1991 79%
eipert et al. (40) 2004 162 1978–1995 83%
resent study 2005 221 1988–2003 85%onduit obstruction has developed in only 5 patients. The sechanism of late conduit obstruction is likely longitudinal
orsion of the conduit during rapid somatic growth in height.
he facility with which this obstruction can be treated by stent
lacement supports this mechanism. Further, serial MRI data
how no decrease in the internal diameter of the conduit after
he first six months.
ATE PULMONARY ARTERY STENOSES. It is interesting that
ate stenosis was seen only in the left pulmonary artery in
ur series. These stenoses were probably related to residual
uctal tissue and become more evident with the growth of
he patients. Further, any central stenosis of the right
ulmonary artery would likely have been treated at the time
f the Glenn anastomosis or at the time of the placement of
he inferior vena cava to right pulmonary artery conduit.
ATE ARRHYTHMIAS. A significant reduction of late atrial
rrhythmias is probably the most important potential ben-
fit of this procedure (10,12–19). Although the impact of
trial arrhythmias on survival in patients with the Fontan
rocedure is not yet clear, the development of supraventricular
achycardia or atrial flutter/fibrillation exposes long-term sur-
ivors to serious morbidity. Kaplan-Meier estimates of free-
om from atrial tachyarrhythmias vary widely from 12.5% to
0%, depending on the Fontan population and the time of the
ollow-up (35–39). Antiarrhythmic drug therapy, antitachycar-
ia pacing, and more recently radiofrequency ablation have
roved useful in controlling the arrhythmias (40). Otherwise
ntreatable arrhythmias have been successfully treated in some
atients by the Mavroudis procedure (41).
The Kaplan-Meier estimates of freedom from arrhythmias
n our series is 83.8% at 15 years. This rate is acceptably low
ompared with the incidence of atrial arrhythmias after atrio-
ulmonary connection (up to 40%) (2–4,40) or after total
avopulmonary intra-atrial connection (up to 20%) (35–39),
lthough the comparison of series is difficult because of
ifferent durations of follow-up.
Our satisfactory long-term data are similar to mid-term
esults reported in 2001 (16,17) and more recently by
akano et al. (19), showing a lower morbidity from arrhyth-
ias than with the lateral tunnel. These last investigators
eported that “the lateral tunnel procedure itself was a
redictor of postoperative supraventricular arrhythmias” and
hese arrhythmias were more frequent in patients with a
igher dilatation ratio of the tunnel and higher plasma atrial
atriuretic peptide level. These data suggest that chronic
tretch of the atrial wall could be an arrhythmogenic
timulus in the lateral tunnel compared with the extracar-
iac conduit. These protective effects of an extracardiac
rocedure on the development of late arrhythmias might be
urther explained by the avoidance of atriotomy and intra-
trial suture lines.
E-INTERVENTIONS. Nine percent (15 of 165) of the re-
nterventions in these patients were attributable to the lack
f a transvenous approach to the atria and the need for
urgical positioning of the pacing leads. Surgical re-
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Outcome of the Extracardiac Fontan May 16, 2006:2065–73ntervention for late obstruction of the extracardiac conduit,
he more controversial aspect of this procedure, occurred in
nly a single patient. Ten additional patients with conduit
r left pulmonary artery stenosis underwent successful bal-
oon dilation or stent implantation.
The poor results of the heart transplantation after extra-
ardiac Fontan in our series (two of three patients died)
onfirm that patients with Fontan failure should be consid-
red high-risk candidates for transplantation, as recently
eported (42). The alternative approach (bidirectional cavo-
ulmonary anastomosis with additional source of pulmonary
lood flow) could represent the best bridge to heart trans-
lantation, by lowering inferior vena caval pressure and
reserving hepatic and renal function (42).
ATE DEATHS. The late deaths occurred after heart trans-
lantation (two patients) and in two patients with a pace-
aker who died suddenly at home. The exact cause of death
n these patients is unknown.
tudy limitations. The most important limitation of this
tudy is the number of patients lost to follow-up. However,
he patients lost to follow-up were not significantly different
n any way from the entire group.
onclusions. After 15 years of follow-up, the overall
urvival, the functional status, and the cardiopulmonary
erformance of survivors of the extracardiac Fontan proce-
ure compare favorably with these parameters in others
eries of patients who underwent surgery with the lateral
unnel approach. The incidence of late deaths, obstructions
f cavopulmonary pathway, re-interventions, and arrhyth-
ias is lower than that reported by others investigators late
fter other Fontan-type operations.
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